Literature DB >> 16586426

Synthesis of some novel azo derivatives of 3,5-dimethyl-1-(2-hydroxyethyl)pyrazole as potent analgesic agents.

E E Oruç1, B Koçyigit-Kaymakçioglu, B Oral, H Z Altunbas-Toklu, L Kabasakal, S Rollas.   

Abstract

A series of 1-(2-hydroxyethyl)-3,5-dimethylpyrazolylazo derivatives, incorporating thiosemicarbazide 2a-c, 1,3,4-thiadiazole 3a-c, and 1,2,4-triazole-3-thione 4a-c were synthesized. The structure of these novel synthesized compounds 2a-c, 3a-c, and 4a-c was confirmed by spectral analysis. All these compounds were screened for their analgesic activity. Hot-plate and tail-immersion tests were used for the determination of the analgesic activity. Morphine, an analgesic through both spinal and supraspinal pathways, was used as a standard test drug. All compounds were administered at a dose of 100 mg/kg i.p. Among the compounds, 2-(butylamino)-5-[((1-(2-hydroxyethyl)-3,5-dimethylpyrazole-4-yl)azo)phenyl]-1,3,4-thiadiazole 3a and 4-[((1-(2-hydroxyethyl)-3,5-dimethylpyrazole-4-yl)azo)phenyl]-4-(2-phenethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione 4c showed analgesic effects in both tests. Especially 4c exerted strong analgesia starting at 30 min after injection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586426     DOI: 10.1002/ardp.200500202

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Design, synthesis, DFT, docking studies and ADME prediction of some new coumarinyl linked pyrazolylthiazoles: Potential standalone or adjuvant antimicrobial agents.

Authors:  Sunil Kumar; Vikram Saini; Indresh K Maurya; Jayant Sindhu; Mukesh Kumari; Ramesh Kataria; Vinod Kumar
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

2.  In vitro characterization of arylhydrazones of active methylene derivatives.

Authors:  Suresh Palanivel; Anastasia Zhurina; Phuong Doan; Jerome G Chandraseelan; Vinoth Kumar Megraj Khandelwal; Fedor I Zubkov; Kamran T Mahmudov; Armando J L Pombeiro; Olli Yli-Harja; Meenakshisundaram Kandhavelu
Journal:  Saudi Pharm J       Date:  2018-01-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.